1. Blum D. Prostate cancer: can we reduce mortality while preserving the quality of life? Washington, DC: US Department of Health and Human Services; 1995. p. 1.
2. Davidson P, Gabbay J. Should mass screening for prostate cancer be introduced at the national level? WHO Regional Office for Europe’s Health Evidence Network Report (HEN), May 2004.
3. Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 2004;171(6 Pt 1):2122–7.
4. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 2006;47(2):287–97.
5. Jacobson AF, Fogelman I. Bone scanning in clinical oncology: does it have a future? Eur J Nucl Med 1998;25(9):1219–23.